| Medical and Health Sciences | Lifetime | 857 | SE 17 | 99.96 |
| Medical and Health Sciences | 2021-2025 | 117 | SE 4 | 99.98 |
| Nephrology | Lifetime | 21 | SE 1 | 99.80 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 493 | SE 9 | 98.49 |
| Medical Physiology | Lifetime | 848 | SE 33 | 98.43 |
| Cardiology and Cardiovascular Medicine | Lifetime | 739 | SE 16 | 98.54 |
| Nutrition and Dietetics | Lifetime | 994 | SE 17 | 94.77 |
| Nephrology | 2021-2025 | 4 | SE 1 | 99.91 |
| Public, Environmental and Occupational Health | 2021-2025 | 227 | SE 1 | 98.06 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 253 | SE 6 | 97.98 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 156 | SE 4 | 97.43 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 342 | SE 2 | 96.70 |
| Epidemiology | 2021-2025 | 781 | SE 9 | 92.34 |
| Medical Physiology | 2021-2025 | 547 | SE 19 | 91.82 |
| Psychiatry and Mental health | 2021-2025 | 598 | SE 27 | 80.93 |
| Dialysis and Renal Disease Management | Lifetime | 16 | SE 2 | 99.84 |
| Chronic Kidney Disease and Diabetes | Lifetime | 41 | SE 1 | 99.65 |
| Nutrition and Health in Aging | Lifetime | 86 | SE 5 | 99.52 |
| Biomarkers in Disease Mechanisms | Lifetime | 17 | SE 2 | 98.57 |
| Potassium and Related Disorders | Lifetime | 32 | SE 2 | 99.29 |
| Diet and metabolism studies | Lifetime | 546 | SE 18 | 98.99 |
| Parathyroid Disorders and Treatments | Lifetime | 157 | SE 8 | 98.83 |
| Blood Pressure and Hypertension Studies | Lifetime | 405 | SE 11 | 98.78 |
| Heart Failure Treatment and Management | Lifetime | 341 | SE 15 | 98.72 |
| Muscle and Compartmental Disorders | Lifetime | 74 | SE 4 | 98.27 |
| Electrolyte and hormonal disorders | Lifetime | 182 | SE 5 | 97.99 |
| Pregnancy and Medication Impact | Lifetime | 218 | SE 12 | 97.40 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 527 | SE 16 | 97.82 |
| Nutritional Studies and Diet | Lifetime | 718 | SE 18 | 97.75 |
| Iron Metabolism and Disorders | Lifetime | 637 | SE 12 | 96.52 |
| Renal Diseases and Glomerulopathies | Lifetime | 719 | SE 11 | 96.88 |
| Renal function and acid-base balance | Lifetime | 547 | SE 12 | 95.05 |
| Pharmacology and Obesity Treatment | Lifetime | 512 | SE 16 | 94.79 |
| Body Composition Measurement Techniques | Lifetime | 671 | SE 21 | 94.34 |
| Acute Kidney Injury Research | Lifetime | 853 | SE 23 | 93.04 |
| Medication Adherence and Compliance | Lifetime | 662 | SE 16 | 92.32 |
| Healthcare cost, quality, practices | Lifetime | 777 | SE 8 | 92.11 |
| Erythropoietin and Anemia Treatment | Lifetime | 642 | SE 16 | 91.74 |
| Magnesium in Health and Disease | Lifetime | 516 | SE 9 | 89.19 |
| Doping in Sports | Lifetime | 511 | SE 14 | 72.91 |
| Dialysis and Renal Disease Management | 2021-2025 | 1 | SE 1 | 99.90 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 3 | SE 1 | 99.83 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 47 | SE 2 | 98.97 |
| Nutritional Studies and Diet | 2021-2025 | 181 | SE 5 | 97.23 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 123 | SE 2 | 97.23 |
| Heart Failure Treatment and Management | 2021-2025 | 187 | SE 4 | 97.77 |
| Diabetes Treatment and Management | 2021-2025 | 280 | SE 6 | 96.91 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 475 | SE 8 | 95.83 |
| Potassium and Related Disorders | 2021-2025 | 32 | SE 3 | 97.24 |
| Pregnancy and Medication Impact | 2021-2025 | 82 | SE 5 | 94.72 |
| Electrolyte and hormonal disorders | 2021-2025 | 78 | SE 2 | 92.14 |
| Nutrition and Health in Aging | 2021-2025 | 708 | SE 13 | 93.10 |
| Renal and Vascular Pathologies | 2021-2025 | 213 | SE 2 | 90.62 |
| Chronic Disease Management Strategies | 2021-2025 | 390 | SE 12 | 90.90 |
| Medication Adherence and Compliance | 2021-2025 | 150 | SE 3 | 90.27 |
| Acute Kidney Injury Research | 2021-2025 | 225 | SE 4 | 91.33 |
| Bipolar Disorder and Treatment | 2021-2025 | 316 | SE 10 | 91.49 |
| Renal function and acid-base balance | 2021-2025 | 79 | SE 2 | 87.24 |
| Healthcare cost, quality, practices | 2021-2025 | 275 | SE 7 | 86.42 |
| Iron Metabolism and Disorders | 2021-2025 | 564 | SE 3 | 85.86 |
| Parathyroid Disorders and Treatments | 2021-2025 | 717 | SE 10 | 82.71 |
| Magnesium in Health and Disease | 2021-2025 | 97 | SE 2 | 78.90 |
| Central Venous Catheters and Hemodialysis | 2021-2025 | 759 | SE 15 | 78.21 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 575 | SE 7 | 62.77 |